Voyager Therapeutics, Inc. (BMV:VYGR)

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.94	71.37	68.8	98.96	117.43	104.44
Short-Term Investments	171.65	195.32	162.07	19.89	15.11	76.7
Cash & Short-Term Investments	215.59	266.68	230.88	118.85	132.54	181.14
Cash Growth	-41.89%	15.51%	94.26%	-10.33%	-26.83%	-35.66%
Accounts Receivable	2.53	2.18	83.49	0.26	0.73	8.01
Other Receivables	-	2.31	0.96	0.38	0.02	0.1
Receivables	2.53	4.49	84.46	0.64	0.75	8.11
Prepaid Expenses	9.77	0.43	0.61	0.7	1.36	1.46
Other Current Assets	-	5.21	3.75	4.32	2.05	7.07
Total Current Assets	227.89	276.81	319.68	124.5	136.7	197.77
Property, Plant & Equipment	44.89	47.66	30	33.34	55.38	61.5
Long-Term Investments	46.45	65.7	-	-	-	-
Other Long-Term Assets	2.87	2.87	1.59	1.52	1.78	2.32
Total Assets	322.1	393.05	351.28	159.36	193.86	261.58
Accounts Payable	1.8	4	1.6	2.57	0.57	0.63
Accrued Expenses	12.03	14.17	16.82	7.82	10.95	14.21
Current Portion of Leases	7.64	7.23	3.2	2.83	5.57	4.2
Current Unearned Revenue	20.52	24.39	42.88	59.38	33.89	7.73
Total Current Liabilities	41.98	49.79	64.51	72.59	50.98	26.77
Long-Term Leases	32.57	36.5	17.09	20.29	38.61	43.41
Long-Term Unearned Revenue	2.61	6	32.36	6.45	8.21	36.09
Other Long-Term Liabilities	1	1	1	1	1	1
Total Liabilities	78.16	93.29	114.96	100.34	98.8	107.26
Common Stock	0.06	0.06	0.04	0.04	0.04	0.04
Additional Paid-In Capital	634.7	626.3	497.51	452.71	442.26	430.32
Retained Earnings	-390.59	-326.18	-261.18	-393.51	-347.1	-275.91
Comprehensive Income & Other	-0.22	-0.41	-0.05	-0.22	-0.14	-0.13
Total Common Equity	243.94	299.76	236.32	59.02	95.06	154.32
Shareholders' Equity	243.94	299.76	236.32	59.02	95.06	154.32
Total Liabilities & Equity	322.1	393.05	351.28	159.36	193.86	261.58
Total Debt	40.2	43.73	20.29	23.13	44.18	47.61
Net Cash (Debt)	221.84	288.66	210.58	95.72	88.36	133.53
Net Cash Growth	-31.55%	37.08%	119.99%	8.33%	-33.83%	-46.43%
Net Cash Per Share	3.81	5.01	4.72	2.50	2.35	3.58
Filing Date Shares Outstanding	55.47	55.21	54.3	43.29	38.11	37.65
Total Common Shares Outstanding	55.43	54.73	44.04	38.61	37.92	37.37
Working Capital	185.91	227.02	255.18	51.91	85.72	171
Book Value Per Share	4.40	5.48	5.37	1.53	2.51	4.13
Tangible Book Value	243.94	299.76	236.32	59.02	95.06	154.32
Tangible Book Value Per Share	4.40	5.48	5.37	1.53	2.51	4.13
Machinery	-	22.67	23.16	22.01	21.91	20.5
Construction In Progress	-	-	-	-	-	0.87
Leasehold Improvements	-	6.49	7.11	12.55	15.7	15.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.